Pharmacology of Geriatric Substance Use Disorders: Considerations and Future Directions
Opinion statement The aging of the baby boomer generation, with its relatively high rates of substance use disorders, will necessitate a broader understanding of the treatment of geriatric addiction and will require greater availability of evidenced-based pharmacological treatment options. The appro...
Gespeichert in:
| Veröffentlicht in: | Current treatment options in psychiatry 2017-03, Vol.4 (1), p.102-115 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 115 |
|---|---|
| container_issue | 1 |
| container_start_page | 102 |
| container_title | Current treatment options in psychiatry |
| container_volume | 4 |
| creator | Hassell, Corey Wilkins, Kirsten Trevisan, Louis A. |
| description | Opinion statement
The aging of the baby boomer generation, with its relatively high rates of substance use disorders, will necessitate a broader understanding of the treatment of geriatric addiction and will require greater availability of evidenced-based pharmacological treatment options. The appropriateness of various treatments depends on the unique needs of this population. Limitations of treatment of substance use disorders in older adults are often attributable to dysfunctions in metabolism, as well as increased risk of adverse effects of certain drugs in the geriatric population. There has been some established success in treating substance use disorders in geriatric populations using currently available pharmacological treatments, however. Considering the available evidence-based treatments for substance use disorders in younger adults and adhering to the classic geriatric dictum of “start low, go slow, and monitor carefully” may serve as useful starting points in treating older adults in the absence of an abundance of high-quality clinical trials to guide evidence-based treatments in this population. |
| doi_str_mv | 10.1007/s40501-017-0107-z |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2804064820</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2804064820</sourcerecordid><originalsourceid>FETCH-LOGICAL-c231z-b01eb2473364cd6ac43124f8884b18ad64d67f377732cb21ba0759748f63fb173</originalsourceid><addsrcrecordid>eNp1kEFLAzEQhYMoWGp_gLeA59WZJE223qTaKhQUtHgM2Wy2bmk3Ndk9tL_e1BX04mGYx_DeG_gIuUS4RgB1EwWMATNAlQZUdjghA4YTmXGQePpHn5NRjGsAQBSAPB-Q95cPE7bG-o1f7amv6NyF2rShtvS1K2JrGuvoMjp6X0cfShfiLZ36JtZJmrZOipqmpLOu7cLRFJz9vl6Qs8psohv97CFZzh7epo_Z4nn-NL1bZJZxPGQFoCuYUJxLYUtprODIRJXnuSgwN6UUpVQVV0pxZguGhQE1niiRV5JXBSo-JFd97y74z87FVq99F5r0UrMcBEiRM0gu7F02-BiDq_Qu1FsT9hpBHxHqHqFOCPURoT6kDOszMXmblQu_zf-HvgB5IHOH</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2804064820</pqid></control><display><type>article</type><title>Pharmacology of Geriatric Substance Use Disorders: Considerations and Future Directions</title><source>SpringerNature Journals</source><creator>Hassell, Corey ; Wilkins, Kirsten ; Trevisan, Louis A.</creator><creatorcontrib>Hassell, Corey ; Wilkins, Kirsten ; Trevisan, Louis A.</creatorcontrib><description>Opinion statement
The aging of the baby boomer generation, with its relatively high rates of substance use disorders, will necessitate a broader understanding of the treatment of geriatric addiction and will require greater availability of evidenced-based pharmacological treatment options. The appropriateness of various treatments depends on the unique needs of this population. Limitations of treatment of substance use disorders in older adults are often attributable to dysfunctions in metabolism, as well as increased risk of adverse effects of certain drugs in the geriatric population. There has been some established success in treating substance use disorders in geriatric populations using currently available pharmacological treatments, however. Considering the available evidence-based treatments for substance use disorders in younger adults and adhering to the classic geriatric dictum of “start low, go slow, and monitor carefully” may serve as useful starting points in treating older adults in the absence of an abundance of high-quality clinical trials to guide evidence-based treatments in this population.</description><identifier>ISSN: 2196-3061</identifier><identifier>EISSN: 2196-3061</identifier><identifier>DOI: 10.1007/s40501-017-0107-z</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Abstinence ; Alcohol use ; Alcohol withdrawal ; Anticonvulsants ; Baby boomers ; Benzodiazepines ; Convulsions & seizures ; Delirium ; Drug dosages ; Drug use ; Drug withdrawal ; Geriatric Disorders (D Steffens and K Zdanys ; Geriatrics ; Medicine ; Medicine & Public Health ; Narcotics ; Neurology ; Older people ; Patients ; Psychiatry ; Section Editors ; Substance use disorder ; Systematic review ; Topical Collection on Geriatric Disorders</subject><ispartof>Current treatment options in psychiatry, 2017-03, Vol.4 (1), p.102-115</ispartof><rights>Springer International Publishing AG (outside the USA) 2017</rights><rights>Springer International Publishing AG (outside the USA) 2017.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c231z-b01eb2473364cd6ac43124f8884b18ad64d67f377732cb21ba0759748f63fb173</citedby><cites>FETCH-LOGICAL-c231z-b01eb2473364cd6ac43124f8884b18ad64d67f377732cb21ba0759748f63fb173</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s40501-017-0107-z$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s40501-017-0107-z$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids></links><search><creatorcontrib>Hassell, Corey</creatorcontrib><creatorcontrib>Wilkins, Kirsten</creatorcontrib><creatorcontrib>Trevisan, Louis A.</creatorcontrib><title>Pharmacology of Geriatric Substance Use Disorders: Considerations and Future Directions</title><title>Current treatment options in psychiatry</title><addtitle>Curr Treat Options Psych</addtitle><description>Opinion statement
The aging of the baby boomer generation, with its relatively high rates of substance use disorders, will necessitate a broader understanding of the treatment of geriatric addiction and will require greater availability of evidenced-based pharmacological treatment options. The appropriateness of various treatments depends on the unique needs of this population. Limitations of treatment of substance use disorders in older adults are often attributable to dysfunctions in metabolism, as well as increased risk of adverse effects of certain drugs in the geriatric population. There has been some established success in treating substance use disorders in geriatric populations using currently available pharmacological treatments, however. Considering the available evidence-based treatments for substance use disorders in younger adults and adhering to the classic geriatric dictum of “start low, go slow, and monitor carefully” may serve as useful starting points in treating older adults in the absence of an abundance of high-quality clinical trials to guide evidence-based treatments in this population.</description><subject>Abstinence</subject><subject>Alcohol use</subject><subject>Alcohol withdrawal</subject><subject>Anticonvulsants</subject><subject>Baby boomers</subject><subject>Benzodiazepines</subject><subject>Convulsions & seizures</subject><subject>Delirium</subject><subject>Drug dosages</subject><subject>Drug use</subject><subject>Drug withdrawal</subject><subject>Geriatric Disorders (D Steffens and K Zdanys</subject><subject>Geriatrics</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Narcotics</subject><subject>Neurology</subject><subject>Older people</subject><subject>Patients</subject><subject>Psychiatry</subject><subject>Section Editors</subject><subject>Substance use disorder</subject><subject>Systematic review</subject><subject>Topical Collection on Geriatric Disorders</subject><issn>2196-3061</issn><issn>2196-3061</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNp1kEFLAzEQhYMoWGp_gLeA59WZJE223qTaKhQUtHgM2Wy2bmk3Ndk9tL_e1BX04mGYx_DeG_gIuUS4RgB1EwWMATNAlQZUdjghA4YTmXGQePpHn5NRjGsAQBSAPB-Q95cPE7bG-o1f7amv6NyF2rShtvS1K2JrGuvoMjp6X0cfShfiLZ36JtZJmrZOipqmpLOu7cLRFJz9vl6Qs8psohv97CFZzh7epo_Z4nn-NL1bZJZxPGQFoCuYUJxLYUtprODIRJXnuSgwN6UUpVQVV0pxZguGhQE1niiRV5JXBSo-JFd97y74z87FVq99F5r0UrMcBEiRM0gu7F02-BiDq_Qu1FsT9hpBHxHqHqFOCPURoT6kDOszMXmblQu_zf-HvgB5IHOH</recordid><startdate>20170301</startdate><enddate>20170301</enddate><creator>Hassell, Corey</creator><creator>Wilkins, Kirsten</creator><creator>Trevisan, Louis A.</creator><general>Springer International Publishing</general><general>Springer Nature B.V</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20170301</creationdate><title>Pharmacology of Geriatric Substance Use Disorders: Considerations and Future Directions</title><author>Hassell, Corey ; Wilkins, Kirsten ; Trevisan, Louis A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c231z-b01eb2473364cd6ac43124f8884b18ad64d67f377732cb21ba0759748f63fb173</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Abstinence</topic><topic>Alcohol use</topic><topic>Alcohol withdrawal</topic><topic>Anticonvulsants</topic><topic>Baby boomers</topic><topic>Benzodiazepines</topic><topic>Convulsions & seizures</topic><topic>Delirium</topic><topic>Drug dosages</topic><topic>Drug use</topic><topic>Drug withdrawal</topic><topic>Geriatric Disorders (D Steffens and K Zdanys</topic><topic>Geriatrics</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Narcotics</topic><topic>Neurology</topic><topic>Older people</topic><topic>Patients</topic><topic>Psychiatry</topic><topic>Section Editors</topic><topic>Substance use disorder</topic><topic>Systematic review</topic><topic>Topical Collection on Geriatric Disorders</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hassell, Corey</creatorcontrib><creatorcontrib>Wilkins, Kirsten</creatorcontrib><creatorcontrib>Trevisan, Louis A.</creatorcontrib><collection>CrossRef</collection><jtitle>Current treatment options in psychiatry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hassell, Corey</au><au>Wilkins, Kirsten</au><au>Trevisan, Louis A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pharmacology of Geriatric Substance Use Disorders: Considerations and Future Directions</atitle><jtitle>Current treatment options in psychiatry</jtitle><stitle>Curr Treat Options Psych</stitle><date>2017-03-01</date><risdate>2017</risdate><volume>4</volume><issue>1</issue><spage>102</spage><epage>115</epage><pages>102-115</pages><issn>2196-3061</issn><eissn>2196-3061</eissn><abstract>Opinion statement
The aging of the baby boomer generation, with its relatively high rates of substance use disorders, will necessitate a broader understanding of the treatment of geriatric addiction and will require greater availability of evidenced-based pharmacological treatment options. The appropriateness of various treatments depends on the unique needs of this population. Limitations of treatment of substance use disorders in older adults are often attributable to dysfunctions in metabolism, as well as increased risk of adverse effects of certain drugs in the geriatric population. There has been some established success in treating substance use disorders in geriatric populations using currently available pharmacological treatments, however. Considering the available evidence-based treatments for substance use disorders in younger adults and adhering to the classic geriatric dictum of “start low, go slow, and monitor carefully” may serve as useful starting points in treating older adults in the absence of an abundance of high-quality clinical trials to guide evidence-based treatments in this population.</abstract><cop>Cham</cop><pub>Springer International Publishing</pub><doi>10.1007/s40501-017-0107-z</doi><tpages>14</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2196-3061 |
| ispartof | Current treatment options in psychiatry, 2017-03, Vol.4 (1), p.102-115 |
| issn | 2196-3061 2196-3061 |
| language | eng |
| recordid | cdi_proquest_journals_2804064820 |
| source | SpringerNature Journals |
| subjects | Abstinence Alcohol use Alcohol withdrawal Anticonvulsants Baby boomers Benzodiazepines Convulsions & seizures Delirium Drug dosages Drug use Drug withdrawal Geriatric Disorders (D Steffens and K Zdanys Geriatrics Medicine Medicine & Public Health Narcotics Neurology Older people Patients Psychiatry Section Editors Substance use disorder Systematic review Topical Collection on Geriatric Disorders |
| title | Pharmacology of Geriatric Substance Use Disorders: Considerations and Future Directions |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T21%3A46%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pharmacology%20of%20Geriatric%20Substance%20Use%20Disorders:%20Considerations%20and%20Future%20Directions&rft.jtitle=Current%20treatment%20options%20in%20psychiatry&rft.au=Hassell,%20Corey&rft.date=2017-03-01&rft.volume=4&rft.issue=1&rft.spage=102&rft.epage=115&rft.pages=102-115&rft.issn=2196-3061&rft.eissn=2196-3061&rft_id=info:doi/10.1007/s40501-017-0107-z&rft_dat=%3Cproquest_cross%3E2804064820%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2804064820&rft_id=info:pmid/&rfr_iscdi=true |